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Osteoarthritis (OA) is a chronic degenerative joint disease that most frequently affects the knee. Patients
complain about pain, muscle weakness, stiffness and instability. This may ultimately lead to a loss of
independence, reduced quality of life and high health-related costs1. Aberrant knee joint loading has been
identified as a potential factor affecting onset and progression of knee OA. The aim of this study is to estimate if
knee joint reaction forces (KCF) during gait differ between healthy adults and subjects with increasing severity of
knee OA using subject-specific musculoskeletal simulations. KCF reflect the combined effect of intersegmental
and musculotendon forces. We hypothesize that subjects with increasing levels of OA involvement, the KCF are
significantly altered due to the combined effect of aberrant movement dynamics, muscle coordination and joint
geometry.
METHODS
Fifty-nine patients (women, mean age of 65.0) were recruited and separated into three groups:
1. Control subjects (n=20) – C0 – asymptomatic, had no history of knee OA or other pathology;
2. Early medial knee OA (n=16) – OA1 – based on novel classification criteria by Luyten et al.2: knee pain, a
K&L grade 0, 1 or 2− and structural changes observed by MRI;
3. Established medial knee OA (n=23) – OA2 – based on slightly adapted ACR classification criteria3: knee
pain, age above 50, stiffness <30 min and crepitus, presence of minimum grade 2+ on K&L scale.
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RESULTS
Using the gait speed as covariate, the 1st peak in total KCF was significantly higher (p = 0.047) in the OA2
comparing to the OA1. Similar changes were reflected in the PD component of the KCF, confirming a
significantly increased 1st peak in OA2 compared to OA1(p = 0.043). The 2nd peak in the medial-lateral
component was also significantly higher for OA2 than for C0 (p = 0.028), but not the first peak.
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Figure 1 - Average KCF during stance Figure 2 - KCF components during
phase across varying OA severities. stance phase across varying OA
severities.
CONCLUSION
 Despite a reduction in self-selected walking speed, total KCF were elevated in people with established OA
except in the terminal stance. This finding suggests that excessive knee joint loading is a contributing factor to
the progression of knee OA.
 Compressive but not medial shear forces were increased in the OA2 indicating that the overloading does
mainly result from strategies that aim to stabilize the joint. Lateral forces were higher during the majority of
stance in these patients, indicative of an unloading strategy of the medial compartment loading.
 KCF could not discriminate early OA patients and C0 subjects. This indicates that knee joint overloading may
only become a contributing factor in the further progression of the disease. Therefore, an early diagnosis and
subsequent therapeutic intervention should be directed to maintaining and stabilizing the loading conditions,
therefore minimizing the role of increased mechanical loading as contributor to disease progression.
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